NEFL and myeloid sarcoma: The application of newer immunoassays has enabled the measurement of the low concentrations of NfL in blood (usually serum) with high accuracy and reproducibility, and increased NfL levels have been found in blood in several neurological disorders with underlying neuro‐axonal degeneration, including MS.3, 4